Alcohol septal ablation for hypertrophic obstructive cardiomyopathy and bilateral lung transplantation for idiopathic pulmonary fibrosis: a case report
- PMID: 37767234
- PMCID: PMC10519878
- DOI: 10.1093/ehjcr/ytad462
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy and bilateral lung transplantation for idiopathic pulmonary fibrosis: a case report
Abstract
Background: We present an uncommon case of a patient with hypertrophic obstructive cardiomyopathy and idiopathic pulmonary fibrosis. The case demonstrates the importance of pre-transplant cardiology workup and the need of interdisciplinary approach in diagnosing the cause of dyspnoea.
Case summary: The 52-year-old male patient was diagnosed with idiopathic pulmonary fibrosis in 2019 and gradually became oxygen dependent due to progression of dyspnoea. Bilateral lung transplantation was recommended in 2021. During pre-transplant cardiology workup, the patient was diagnosed with hypertrophic cardiomyopathy with left ventricular outflow tract (LVOT) obstruction. Considering the high surgical risk of the patient, alcohol septal ablation was performed with subsequent decrease of LVOT gradient. Bilateral lung transplantation was successfully performed afterwards. The patient's symptoms improved to NYHA class II at one year follow-up.
Discussion: We present a rare case of combined cause of dyspnoea-coexistence of hypertrophic obstructive cardiomyopathy and idiopathic pulmonary fibrosis in one patient. Due to high surgical risk, the patient underwent alcohol septal ablation with successful elimination of LVOT gradient and subsequently bilateral lung transplantation.
Keywords: Alcohol septal ablation; Case report; Hypertrophic obstructive cardiomyopathy; Idiopathic pulmonary fibrosis; Lung transplantation.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: None declared.
Figures






Similar articles
-
Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.Rev Port Cardiol (Engl Ed). 2019 Jul;38(7):473-480. doi: 10.1016/j.repc.2019.08.003. Epub 2019 Sep 5. Rev Port Cardiol (Engl Ed). 2019. PMID: 31495717 English, Portuguese.
-
Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.Catheter Cardiovasc Interv. 2020 Mar 1;95(4):830-837. doi: 10.1002/ccd.28442. Epub 2019 Aug 13. Catheter Cardiovasc Interv. 2020. PMID: 31410979
-
Radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a case report.Eur Heart J Case Rep. 2024 Jul 23;8(8):ytae359. doi: 10.1093/ehjcr/ytae359. eCollection 2024 Aug. Eur Heart J Case Rep. 2024. PMID: 39108996 Free PMC article.
-
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective.J Clin Med. 2023 Apr 11;12(8):2810. doi: 10.3390/jcm12082810. J Clin Med. 2023. PMID: 37109147 Free PMC article. Review.
-
Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.Eur J Cardiothorac Surg. 2023 Mar 1;63(3):ezad043. doi: 10.1093/ejcts/ezad043. Eur J Cardiothorac Surg. 2023. PMID: 36782361
References
-
- Hardy JD, Webb WR, Dalton ML Jr, Walker GR. Lung homotransplantation in man: report of the initial case. JAMA 1963;186:1065–1074. - PubMed
-
- Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med 2011;184:159–171. - PubMed
-
- De Vito Dabbs A, Song MK. Risk profile for cardiovascular morbidity and mortality after lung transplantation. Nurs Clin North Am 2008;43:37–53. - PubMed
-
- Chaikriangkrai K, Jyothula S, Jhun HY, Estep J, Loebe M, Scheinin S, et al. . Impact of pre-operative coronary artery disease on cardiovascular events following lung transplantation. J Heart Lung Transplantat 2016;35:115–121. - PubMed
Publication types
LinkOut - more resources
Full Text Sources